跳至主要内容
临床试验/ISRCTN94514482
ISRCTN94514482
已完成
不适用

A 3-arm randomised controlled parallel group trial to determine the efficacy of pulmonary rehabilitation in moderate Chronic Obstructive Pulmonary Disease (COPD) patients in primary health care and maintenance of benefits at 2 years

TV3 Marathon Foundation (Fundació La Marató de TV3) (Spain)0 个研究点目标入组 97 人2010年2月11日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Chronic Obstructive Pulmonary Disease
发起方
TV3 Marathon Foundation (Fundació La Marató de TV3) (Spain)
入组人数
97
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2010年2月11日
结束日期
待定
最后更新
11年前
研究类型
Interventional
性别
All

研究者

发起方
TV3 Marathon Foundation (Fundació La Marató de TV3) (Spain)

入排标准

入选标准

  • 1\. Clinical diagnosis of COPD with values of forced spirometry after broncodilatation of the ratio Forced Expiration Volume in 1 second (FEV1\) / Forced Vital Capacity (FVC) less than 0\.7 and FEV1 between 30% and 80% of its reference values (Global Initiative for Chronic Obstructive Lung Disease \[GOLD] criteria of moderate COPD).
  • 2\. Age between 35 and 74 years old.
  • 3\. No experience of exacerbation or hospital admission in the month before inclusion.
  • 4\. Willingness to participate in the study and signed informed consent.
  • Smoking will not be considered as an exclusion criterion.

排除标准

  • 1\. Patients with severe and very mild COPD
  • 2\. FEV1\<30% and \>80%
  • 3\. Relevant osteoarticular disease or other debilitating diseases that could affect normal ambulation
  • 4\. Other important diseases that can impede follow\-up (terminal patients, inmunodeficiencies, chronic infections)
  • 5\. Ischaemic heart disease, clinically evident, severe or uncontrolled systemic arterial hypertension.

结局指标

主要结局

未指定

相似试验